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A matricellular protein fibulin-4 is essential
for the activation of lysyl oxidase
Kazuo Noda1,2*, Kaori Kitagawa1*, Takao Miki1, Masahito Horiguchi3, Tomoya O. Akama1,
Takako Taniguchi4, Hisaaki Taniguchi4, Kazuaki Takahashi5, Yasumitsu Ogra5,
Robert P. Mecham6, Masahiko Terajima7, Mitsuo Yamauchi7, Tomoyuki Nakamura1†

INTRODUCTION

Elastic fibers and collagen fibers are the major extracellular matrices
(ECMs) that confer resilience and tensile strength on tissues, respectively. Elastic fibers are assembled from elastin protein aggregates deposited onto microfibrils (1), and collagen fibers consist of
bundles of collagen fibrils that are formed by the self-assembly of
triple-helical collagen molecules (2). Both elastin and collagen fibers undergo extensive lysine-derived cross-linking outside the cell
to form the stable polymers that define their functional forms. Although elastin and collagens do not share similar sequences, the
cross-linking of both proteins is initiated by the same enzyme, lysyl
oxidase (LOX) (3, 4).
LOX is a member of a copper amine oxidase family that includes
LOX and LOX-like (LOXL) 1 to 4. LOX family members contain a
highly conserved catalytic domain with a lysine tyrosyl quinone
(LTQ) redox cofactor and a conserved copper-binding site in the
C-terminal half of the protein (5, 6). The N-terminal domains are
variable in length and sequence, and those of LOX and LOXL1
function as propeptides, as they are proteolytically cleaved to release
active enzyme (7). The propeptides are considered to function in
secretion and distribution of the enzymes, suppression of the enzyme
activity until proteolytically removed, or modulation of cell signaling
(8, 9). LOXL2 to LOXL4 comprise a subfamily whose N-terminal
domains contain scavenger receptor cysteine-rich domains, the function of which is not well understood (8). Mice deficient in LOX (Lox−/−)
show defective cross-linking of elastin and collagen that leads to severe
aortic aneurysm and emphysematous lungs and die perinatally due

1

Department of Pharmacology, Kansai Medical University, Hirakata, Osaka 573-1010,
Japan. 2Department of Plastic and Reconstructive Surgery, Graduate School of
Medicine, Kyoto University, Kyoto 606-8507, Japan. 3Department of Emergency
Medicine, Japanese Red Cross Society Kyoto Daiichi Hospital, Kyoto 605-0981,
Japan. 4Division of Disease Proteomics, Institute for Enzyme Research, Tokushima
University, Tokushima 770-8503, Japan. 5Laboratory of Toxicology and Environmental Health, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba
260-8675, Japan. 6Department of Cell Biology and Physiology, Washington University School of Medicine, Saint Louis, MO 63110, USA. 7Division of Oral and Craniofacial
Health Sciences, Adams School of Dentistry, University of North Carolina, Chapel
Hill, NC 27599, USA.
*These authors contributed equally to this work.
†Corresponding author. Email: nakamtom@hirakata.kmu.ac.jp
Noda et al., Sci. Adv. 2020; 6 : eabc1404

25 November 2020

to aortic and diaphragmatic rupture (10, 11). In contrast, mice deficient in either of LOXL1 to LOXL3 survive to adulthood and show
much less severe phenotypes than Lox−/− mice (12–14). Mice deficient in LOXL4 have not been reported. Therefore, LOX is considered to be the enzyme that plays a major role in cross-linking elastin
and collagen, at least in the developmental stage.
The LOX enzyme is activated extracellularly when the propeptide is proteolytically removed from the proenzyme (proLOX) by
the proteases bone morphogenetic protein 1 (BMP-1) or mammalian Tolloid-like 1 (mTLL-1), resulting in release of the catalytically
active mature LOX (fig. S1, A and C) (15). Both copper binding and
LTQ formation, which occur in the trans-Golgi network (TGN), are
required for full enzyme activity. Copper binding to key histidine
residues in LOX facilitates the formation of LTQ, an intramolecular
cross-link between Lys314 and Tyr349 side chains (in the case of murine LOX) (fig. S1B) (5).
The fibulins are a family of matricellular proteins that function
in the ECM but do not play a structural role (16). Fibulin-4, along
with its closely related paralog fibulin-5, plays an essential role in
elastogenesis. Mice deficient in fibulin-5 (Fbln5−/−) survive to adulthood, but exhibit severe emphysema, stiff and tortuous arteries, and
loose skin, due to defective elastogenesis (17, 18). Collagen fibers
are not affected, and aneurysms are not found in these mice. Mice
deficient in fibulin-4 (Fbln4−/−), in contrast, show phenotypes that
closely overlap with those of Lox−/− mice, including perinatal lethality
due to aortic and diaphragmatic rupture, severe aortic aneurysms,
and emphysematous lungs, with severely disrupted elastic fibers and
abnormal collagen fibers (19, 20). These phenotypic similarities suggest a functional link between fibulin-4 and LOX. Our previous data
showed that the LOX propeptide interacts with fibulin-4, but not
with fibulin-5 (17, 21). However, whether fibulin-4 is necessary for
LOX activity has been elusive.
To elucidate whether and how fibulin-4 influences LOX activity,
we explored the nature of LOX produced in the absence of fibulin-4.
Here, we report that LOX secreted from Fbln4−/− cells is inactive
due to the inability of LOX to form the LTQ cofactor. We show that
fibulin-4 is required for copper ion transfer from the copper transporter ATP7A to proLOX in the lumen of TGN. We also report that
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Fibulin-4 is a matricellular protein required for extracellular matrix (ECM) assembly. Mice deficient in fibulin-4
(Fbln4−/−) have disrupted collagen and elastin fibers and die shortly after birth from aortic and diaphragmatic
rupture. The function of fibulin-4 in ECM assembly, however, remains elusive. Here, we show that fibulin-4 is required for the activity of lysyl oxidase (LOX), a copper-containing enzyme that catalyzes the covalent cross-linking
of elastin and collagen. LOX produced by Fbln4−/− cells had lower activity than LOX produced by wild-type cells
due to the absence of lysine tyrosyl quinone (LTQ), a unique cofactor required for LOX activity. Our studies showed
that fibulin-4 is required for copper ion transfer from the copper transporter ATP7A to LOX in the trans-Golgi network (TGN), which is a necessary step for LTQ formation. These results uncover a pivotal role for fibulin-4 in the
activation of LOX and, hence, in ECM assembly.
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secreted fibulin-4 can be internalized by endocytosis and contribute
to the activation of LOX in the TGN. These results establish a pivotal role for fibulin-4 as an indispensable partner of LOX for its enzymatic activity.
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LOX produced in the absence of fibulin-4 has altered
posttranslational modification
To examine whether loss of fibulin-4 affects LOX protein in vivo,
we performed Western blot analyses with an anti-LOX antibody of
mouse neonatal aortic tissue extract. We detected only mature LOX
enzyme without the propeptide; no proLOX was detectable in these
tissues. Levels of mature LOX in Fbln4−/− tissues were comparable
to those in wild-type (WT) aorta (Fig. 2A). However, mature LOX
from Fbln4−/− aortic tissues, but not from Fbln5−/− aortic tissues,
migrated slightly slower in SDS–polyacrylamide gel electrophoresis
(SDS-PAGE) than LOX from WT aortic tissues (Fig. 2A).
This mobility shift was also evident in cell culture experiments
where endogenously expressed LOX secreted into the culture medium of Fbln4−/− mouse embryonic fibroblasts (MEFs) migrated in
SDS-PAGE slower than that from WT MEFs (Fig. 2, B and C). Lentiviral expression of full-length WT fibulin-4 in Fbln4−/− MEFs
reversed the mobility shift, with secreted LOX running at a size equivalent to the WT protein. Lentiviral expression of fibulin-4 with the
E57K mutation only partially rescued the mobility shift of LOX, and
no rescue was observed with N-terminal deletion mutant of fibulin-4
or full-length fibulin-5 (Fig. 2, B and C). LOX-FLAG secreted from
Fbln4−/− MEFs infected with a lentivirus expressing C-terminally
FLAG-tagged proLOX complementary DNA (cDNA) also exhibited
delayed migration, indicating that the mobility shift was caused by
altered posttranslational modification and not by alternative splicing
(Fig. 2, D and E).
Fibulin-4 is necessary for LOX enzymatic activity
To explore the functional differences between the two forms of LOX,
we purified endogenously expressed LOX from the conditioned medium of WT and Fbln4−/− MEFs (Fig. 3A) and measured LOX enzymatic activity using tritiated tropoelastin as a substrate. LOX from
Fbln4−/− MEFs was substantially less active than an equivalent amount
of WT LOX (Fig. 3B). Consistent with this finding, levels of des25 November 2020
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Fig. 1. An in vitro binding assay showing a domain-specific binding of fibulin-4
(FBLN4) with proLOX. (A) Domain structure of FLAG-tagged full-length fibulin-4
and fibulin-4 mutants (E57K, N1, and N2) and Myc-tagged proLOX used in the
assay. (B) In vitro binding assay using the conditioned medium from 293T (BMP1−/−)
cells transfected with plasmids encoding the cDNAs shown in (A). The lysates were
mixed and immunoprecipitated with anti-FLAG agarose beads, followed by SDS-PAGE
and Western blotting using anti-Myc and anti-FLAG antibodies (Ab). Note strong
binding of proLOX with WT fibulin-4, while the binding was much weaker with
E57K mutant fibulin-4 and even weaker with N-terminal deletion mutants.

mosine and isodesmosine, LOX-derived cross-links in elastin, and
pyridinoline, a cross-link in collagen, were greatly reduced in neonatal aortae of both Fbln4−/− and Lox−/− mice compared to WT neonatal
mouse aortae (Fig. 3, C and D). These results indicate that fibulin-4 is
essential for the full enzymatic activity of LOX in vitro and in vivo.
Fibulin-4 is necessary for LTQ formation in LOX
There are four known posttranslational modifications of proLOX:
glycosylation of the propeptide (23), cleavage of the propeptide (24),
sulfation of tyrosine residues in LOX enzyme domain (25), and LTQ
formation after copper ion binding (5). Because all potential glycosylation sites are within the propeptide (23), this modification cannot cause the mobility shift of mature LOX enzyme after cleavage of
the propeptide. We then examined whether the cleavage site of
proLOX differs between WT and Fbln4−/− cells. The N-terminal
sequences of mature LOX purified from the conditioned medium of
WT and Fbln4−/− MEFs were analyzed by Edman degradation. There
was no difference in amino acid sequence between the genotypes,
indicating that the mobility shift of LOX produced by Fbln4−/− cells
2 of 10

Downloaded from http://advances.sciencemag.org/ on January 11, 2021

The N-terminal domain of fibulin-4 is required
for interaction with proLOX
A homozygous N-terminal missense mutation in the human FBLN4
gene (E57K) was reported to cause cutis laxa syndrome, with ascending aortic aneurysms, arterial tortuosity, emphysema, and joint
laxity (22). Because we previously showed that fibulin-4 interacts
with the propeptide domain of proLOX (21), we examined whether
the interaction between the two proteins is affected by mutation or
truncation within the N-terminal region of fibulin-4. We used an
in vitro binding assay using fibulin-4 mutants and proLOX overexpressed by 293T engineered by CRISPR-Cas9–based gene targeting
to inactivate BMP-1 and avoid propeptide cleavage. The results confirmed that the interaction between the two proteins is largely dependent on the N-terminal domain of fibulin-4, as proLOX did not
coprecipitate with N-terminal fibulin-4 deletion mutants (∆N1 and
∆N2). Similarly, the E57K mutant of fibulin-4 reacted only weakly
with proLOX (Fig. 1).
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Fig. 2. Mobility shift of LOX produced in the absence of fibulin-4 in SDS-PAGE.
(A) Western blot analysis with anti-LOX antibody (left) and amido black staining of
the same membrane (right) of mouse neonatal aortic tissue lysate (a pup/lane) of
the indicated genotype. Note that LOX from Fbln4−/− aortic tissues migrated slightly
slower than that from WT and Fbln5−/− tissues (open arrowheads). (B) Western blot
analysis of LOX endogenously expressed by WT and Fbln4−/− MEFs. Note the distinct effects of lentiviral overexpression of HA-tagged fibulin-4 (HA-FBLN4 WT),
E57K mutant fibulin-4 (HA-FBLN4 E57K), N-terminally deleted fibulin-4 (HA-FBLN4
N1), and full-length fibulin-5 (HA-FBLN5) on LOX migration. (C) Ratio of the quantified intensity of lower and upper bands of LOX. (D) Western blot analysis of overexpressed LOX by infecting WT and Fbln4−/− MEFs with C-terminally FLAG-tagged
proLOX (proLOX-FLAG) lentivirus. Note the mobility shift of LOX-FLAG secreted by
Fbln4−/− MEFs and distinct effects of lentiviral overexpression of HA-FBLN4 WT,
HA-FBLN4E57K, HA-FBLN4 N1, and HA-FBLN5 on LOX-FLAG migration. (E) Ratio
of the quantified intensity of lower and upper bands of LOX-FLAG. Bar graphs show
mean ± SEM (n = 4). ***P < 0.001 compared with WT MEFs.

was not caused by an alternative propeptide cleavage site (fig. S1C).
Similarly, the sulfation of LOX tyrosine residues does not account
for the mobility shift, because YF mutant of LOX, in which potentially sulfated tyrosine residues were substituted by phenylalanine
residues (25), showed a mobility shift similar to WT LOX when produced by Fbln4−/− MEFs (fig. S2).
To examine whether the LOX mobility shift was related to loss of
LTQ formation, we mutated the lysine (K314A) or tyrosine (Y349A)
Noda et al., Sci. Adv. 2020; 6 : eabc1404
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Fig. 3. Requirement of fibulin-4 for the enzymatic activity of LOX in vitro and
in vivo. (A) Amido black staining of LOX protein purified from conditioned medium of WT and Fbln4−/− MEFs, transferred to a membrane after SDS-PAGE. Note that
LOX from Fbln4−/− MEFs (open arrowhead) migrated slower by SDS-PAGE than that
from WT MEFs (closed arrowhead). (B) Enzymatic activity of purified endogenous
LOX from WT and Fbln4−/− MEFs. Bar graphs show mean ± SEM (n = 4). **P < 0.01.
dpm, disintegration per minute. (C and D) Desmosine and isodesmosine (C) and
pyridinoline (D) in neonatal aortae from each genotype. Four samples were collected
for one analyte. Bar graphs show mean ± SEM (n = 5). *P < 0.05, **P < 0.01, and ***P <
0.001 compared with WT.

residues that form LTQ. Figure 4A shows that either mutation introduced into LOX caused delayed migration by SDS-PAGE similar
to that found with LOX produced by Fbln4−/− cells. Thus, the failure
to form LTQ can cause the mobility shift. Quinoproteins are detected by staining with nitro blue tetrazolium (NBT), which is reduced
to a colored formazan by the redox-cycling property of quinones
(26). LOX purified from conditioned medium of WT MEFs, separated by SDS-PAGE and electroblotted to a membrane, was intensely
stained by NBT. In contrast, staining of LOX produced by Fbln4−/−
MEFs was largely diminished, suggesting that the latter contains
much less LTQ (Fig. 4, B and C). Furthermore, LOX from Fbln4−/−
MEFs appeared as two bands by amido black staining of the membrane, but only the minor lower band was stained by NBT (Fig. 4C).
These data suggest that the lower band corresponds to LTQ-containing
LOX, whereas the upper band is LOX that lacks LTQ. To directly
measure LTQ levels, purified LOX was labeled with phenylhydrazine
and digested with trypsin/Lys-C and Asp-N to generate the LTQ
cross-link–containing peptide. Orbitrap mass spectrometric analysis
(fig. S3) showed that the level of cross-linked peptide in the digest of
LOX secreted from Fbln4−/− MEFs was markedly reduced compared
to that in the digest of LOX secreted from WT MEFs (Fig. 4D).
Together, these results indicate that fibulin-4 plays a necessary role
in the formation of LTQ in LOX.
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Fibulin-4 promotes copper ion transfer from copper
transporter ATP7A to proLOX
LTQ formation involves copper ion bound to specific histidine residues in proLOX (5). Copper loading occurs in the TGN and is dependent on the transfer of copper from the cytoplasm to proLOX in
the lumen of the TGN by the copper transporter ATP7A (fig. S1A)
(5, 6). Therefore, we determined whether deficient LTQ formation
in LOX produced by Fbln4−/− cells was due to reduced copper ion
incorporation into proLOX. Endogenously expressed LOX from
Atp7a−/− MEFs showed delayed migration in SDS-PAGE relative to
Noda et al., Sci. Adv. 2020; 6 : eabc1404
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LOX from WT MEFs, which was reversed by lentiviral expression
of ATP7A (Fig. 5, A and B). Overexpressed LOX-FLAG from Atp7a−/−
MEFs also showed delayed migration in SDS-PAGE similar to that
from Fbln4−/− MEFs (Fig. 5C). In addition, LOX mutants in which
copper-binding histidine residues were substituted by alanine residues to block copper binding showed similar mobility shift in SDSPAGE, even when they were expressed by WT MEFs (Fig. 5D). Last,
we measured copper ion bound to LOX purified from the culture
medium of WT MEFs and Fbln4−/− MEFs, using inductively coupled plasma–mass spectrometry (ICP-MS). We found that copper
ion bound to LOX produced by Fbln4−/− MEFs was markedly reduced compared to that produced by WT MEFs (Fig. 5E). These
data suggest that loss of fibulin-4 causes a deficiency in copper ion
incorporation into LOX, which results in defective LTQ formation.
To explore the mechanism by which fibulin-4 influences copper
ion transfer from ATP7A to proLOX, we performed an in vitro binding assay using recombinant hemagglutinin (HA)–tagged fibulin-4
and FLAG-tagged ATP7A overexpressed by 293T cells. Our results
showed interaction between the two proteins (Fig. 5F). Both the
N-terminal and C-terminal FLAG-tagged halves of ATP7A interacted with HA-tagged fibulin-4 (fig. S4), suggesting that there are
multiple binding sites for fibulin-4 within ATP7A. Protein mapping
studies with fragments of fibulin-4 identified the middle cbEGF-like
repeat (M domain) and the C-terminal fibulin-type motif (C domain)
as the domains for binding to ATP7A. No interaction was found with
the N-terminal domain of fibulin-4, indicating that the ATP7A-binding
site resides in the M and C domain of fibulin-4 (Fig. 5G). These findings support a model where the N-terminal domain of fibulin-4 binds
the propeptide domain of proLOX and the downstream M and C
domains interact with ATP7A. In this way, fibulin-4 may function
as a linker to facilitate direct copper ion transfer from ATP7A to
proLOX (Fig. 6I).
Secreted fibulin-4 can be internalized by endocytosis
and contribute to LTQ formation of LOX
An unexpected finding in our studies was the observation that low
concentration (1 to 2 nM) of recombinant fibulin-4 added to culture medium reversed the mobility shift of LOX secreted by Fbln4−/−
MEFs (Fig. 6A). The addition of 8 nM of recombinant fibulin-5,
however, had no effect, nor did the N, M, or C fragment of fibulin-4
(fig. S5). Because ATP7A is not located on the cell surface in normal
medium with low copper concentration (27), this result led us to
hypothesize that exogenous fibulin-4 can be internalized and transported to the TGN lumen, where copper ion transfer to proLOX
occurs (27). To test this hypothesis, we incubated MEF cells with
recombinant FLAG-tagged fibulin-4 and anti-FLAG antibody at 4°C
to inhibit internalization of the cell surface–bound protein. The cells
were then warmed to 37°C to allow internalization of cell surface
receptor–bound molecules. After acid washing to remove remaining cell surface proteins, internalized fibulin-4 was detected by immuno
fluorescent staining (Fig. 6, B to E). Internalization was partially
inhibited by Dynasore, a dynamin inhibitor (28), and Filipin, an inhibitor of caveolae-mediated endocytosis (29), suggesting that fibulin-4
can be internalized by caveolae-mediated endocytosis. We cannot,
however, exclude the possibility that fibulin-4 can also be internalized
by clathrin-mediated endocytosis (Fig. 6F). To address whether exogenous fibulin-4 needs to be internalized to induce LTQ formation
in LOX produced by Fbln4−/− MEFs, we added Dynasore in the same
settings as Fig. 6A. The induction of LTQ formation by recombinant
4 of 10
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(A) Western blot analysis of LOX endogenously expressed by WT and Atp7a−/−
MEFs, with or without ATP7A overexpression by lentivirus. (B) Ratio of the quantified intensity of lower and upper bands of LOX. Bar graphs show mean ± SEM
(n = 3). ***P < 0.001 compared with WT MEFs. (C) Western blot analysis of LOX-FLAG
overexpressed by WT, Atp7a−/−, and Fbln4−/− MEFs. (D) Western blot analysis of
LOX-FLAG mutants, in which copper-binding histidines were substituted by alanines, secreted from WT and Fbln4−/− MEFs. (E) Quantification of copper incorporated in purified LOX by ICP-MS analysis. Bar graphs show mean ± SEM (triplicate
measurements). ***P < 0.001. (F) An in vitro binding assay showing interaction of
recombinant HA-tagged fibulin-4 and FLAG-tagged ATP7A overexpressed by 293T
cells. FLAG-tagged bacterial alkaline phosphatase (FLAG-BAP) was used as a negative control. (G) In vitro binding assay for determining ATP7A-binding domain of
fibulin-4. FLAG-tagged full-length fibulin-4 or the N, M, or C domain of fibulin-4
fused with immunoglobulin Fc region (Ig) was coimmunoprecipitated with Myctagged ATP7A.

fibulin-4 was significantly inhibited by Dynasore (Fig. 6G), and
the levels of inhibition were comparable to that of endocytosis of
fibulin-4 by the same concentration of Dynasore (Fig. 6F). Immunofluorescent staining of internalized fibulin-4 and the TGN marker
Golgin-97 (30) revealed colocalization of these proteins (Fig. 6H).
The cell surface attachment and the retrograde trafficking to the
TGN were observed with full-length fibulin-4, but not with the N,
M, or C fragment of fibulin-4 (fig. S6). These data suggest that some
of the internalized fibulin-4 reaches the TGN, where copper ion
transfer to proLOX occurs.
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In the present study, we identified an essential role for fibulin-4 in
the activation of LOX. Our proposed model is illustrated in Fig. 6I.
Fibulin-4 interacts with ATP7A through its middle and C-terminal
domain and thereby facilitates copper ion transfer from ATP7A to
N-terminally bound proLOX. Because copper ion bound to specific
histidine residues of proLOX is necessary for LTQ formation, fibulin-4
is crucial for generating active LOX. Without fibulin-4, the efficiency
of copper ion transfer and subsequent LTQ formation are largely
diminished (Fig. 5E), leading to production of inactive LOX.
We previously reported that the fibulin-4 interacts with LOX
propeptide and with tropoelastin (21). This potential ability to bridge
proLOX and tropoelastin could explain a part of the specific role for
fibulin-4 in elastic fiber assembly; however, it cannot account for
the nearly identical phenotypes of Fbln4−/− and Lox−/− mice that include collagen fiber abnormality in addition to elastic fiber deficiency
(10, 11, 19). Our findings that fibulin-4 is necessary for LOX activity
and that both elastin and collagen cross-links are greatly reduced in
Fbln4−/− mouse tissues reconcile this phenotypic similarity.
Sasaki et al. (20) reported that osteoblasts from Fbln4−/− mice
produce less mature LOX and suggested its mechanism as reduced
processing of proLOX in the absence of fibulin-4. In our experiments with aortic tissues and MEFs with intact BMP-1, however, we
did not observe the bands that correspond to unprocessed proLOX,
in the absence or presence of fibulin-4 (fig. S7). Our data suggest
that altered processing of proLOX is not a general mechanism by
which the absence of fibulin-4 affects LOX activity.
In humans, homozygous or compound heterozygous mutations
in the FBLN4 gene are reported in autosomal recessive cutis laxa
characterized by loose skin, arterial tortuosity and aneurysms, emphysema, and skeletal abnormality (31). Among these mutations,
the E57K missense mutation is located at the N-terminal domain
and is not assumed to affect the conformation of most of the protein
(32). Homozygous Fbln4 E57K mutant mice are reported to survive
to adulthood and exhibit aortic aneurysm, arterial tortuosity, and
emphysema, which recapitulate the human FBLN4E57K/E57K mutant
phenotypes (33). Reduced binding of the E57K mutant fibulin-4
with proLOX (Fig. 1) and weak ability to induce LTQ formation in
LOX (Fig. 2, B and C) are consistent with the less severe phenotypes
of human and mouse mutants than those of Fbln4−/− mice.
Among the eight members of the fibulin family, fibulin-3, fibulin-4,
and fibulin-5 share homology in sequence and domain configuration and are termed “short fibulins” or “elastogenic fibulins” because
of their size and the phenotypes of the mice deficient in these genes
(31). Fbln5−/− mice survive to adulthood and show stiff and tortuous arteries, emphysematous lungs, and loose skin, due to defective
elastogenesis (17, 18). Unlike Fbln4 mutant mice, however, Fbln5−/−
mice do not show aneurysms. We previously reported that fibulin-5
promotes coacervation of elastin and recruits elastin onto micro
fibrils (34). Considering that the loss of fibulin-5 is not compensated
for by the presence of other fibulins including fibulin-4, these unique
functions of fibulin-5 in elastic fiber assembly do not overlap with
those of fibulin-4. Conversely, we reason that the role for fibulin-4
in the activation of LOX is not shared by other elastogenic fibulins,
as fibulin-5 cannot interact with proLOX, and loss of fibulin-4 cannot be compensated for by the presence of other fibulins. However,
it is possible that fibulin-5 also contributes to the formation of LTQ
in LOXL1, because fibulin-5 interacts with LOXL1 and LOXL1 plays
an important role in elastogenesis (12, 34). The function of fibulin-3
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is not clear, as Fbln3−/− mice show only minor elastic fiber defect in
fascia (35).
Because the reduced LOX activity has been associated with mutations of the human or mouse ATP7A gene, copper incorporation
into proLOX is assumed to be mediated by copper transporter
ATP7A (27). However, a protein that functions to mediate the transfer
Noda et al., Sci. Adv. 2020; 6 : eabc1404
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of copper from ATP7A to proLOX has not been anticipated. We
showed that fibulin-4 promotes copper ion transfer from ATP7A to
proLOX in the Golgi, which is a necessary step for generation of
LTQ, a critical cofactor for the oxidase activity. Our studies suggest
the existence of similar bridging proteins for other copper-dependent
enzymes, too, such as tyrosinase or peptidylglycine -amidating
6 of 10
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MATERIALS AND METHODS

Mice
All mice used here were maintained on normal laboratory diet.
Fbln4−/−, Fbln5−/−, and Lox−/− mice were previously described (19, 17, 10)
and maintained in Kansai Medical University. All procedures were
approved by the Committee for Animal Experiments of Kansai Medical
University and conducted according to the Guideline for Animal
Experimentation at Kansai Medical University.
Antibodies
Primary antibodies used were anti-FLAG (Sigma-Aldrich, F1804),
anti-Myc and anti-HA (Medical & Biological Laboratories Co., M192-3S
and M180-3, respectively), anti-LOX (Abcam, ab31238), anti-ATP7A
(Abcam, ab13995), and anti–Golgin-97 (Cell Signaling Technology,
13192) antibodies. Secondary antibodies used were horseradish
peroxidase–conjugated anti-mouse immunoglobulin G (IgG), anti-
rabbit IgG, and anti-chicken IgY (Abcam, ab205719, ab6721, and
ab6877, respectively) and Alexa Fluor 488–conjugated anti-mouse
IgG and Alexa Fluor 555–conjugated anti-rabbit IgG (Thermo Fisher
Scientific, A-11029 and A-31572, respectively).
Cell culture and genome editing
MEFs and 293T cells were maintained in Advanced DMEM
(Dulbecco’s modified Eagle’s medium) (Thermo Fisher Scientific)
Noda et al., Sci. Adv. 2020; 6 : eabc1404
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supplemented with 2 mM glutamine, penicillin/streptomycin
(100 U/100 mg ml−1), and 5% fetal bovine serum at 37°C in 5% CO2.
MEFs were harvested from WT and Fbln4−/− mouse embryo and
immortalized by transferring with human telomere reverse transcriptase cDNA. For the purification of endogenous LOX from MEFs, a
monoclonal cell line expressing high-level LOX was selected by limiting dilution of immortalized WT MEFs, followed by Fbln4 gene
deletion using the CRISPR-Cas9 system with double-nicking strategy (37). Fbln4 single-guide RNA (sgRNA) pairs (5′-agagcagcaaa
gacccgggg-3′ and 5′-ggcgtttctgctgttgctct-3′) were cloned into Bbs
I–digested plasmid pX335 (42335, Addgene). The plasmids were
transduced into WT MEFs followed by clonal isolation and expansion. Targeted region was amplified from genomic DNA, and indel
mutations were validated by Sanger sequencing. Atp7a−/− MEFs
were generated in the same manner using Atp7a sgRNA pairs (5′-
aacagtcaggaacacggtat-3′ and 5′-ctgctccactgactctgcct-3′). To obtain
BMP1−/− 293T cells and Bmp1−/− MEFs, BMP1 sgRNA pairs (5′cgacgacgtggcccagctcg-3′ and 5′-cgaacacactcggccagacc-3′) and Bmp1
sgRNA pairs (5′-gggccacacccgctccggtc-3′ and 5′-ggggtcatcccgtttgtgat-3′) were used, respectively.
Plasmid construction, lentiviral gene transfer, and
protein purification
FBLN4-WT, FBLN5, and LOX cDNA were subcloned as previously
described (21, 34). FBLN4-E57K, FBLN4-N1 (Q28-R53), FBLN4N2 (D54-V122), FBLN4-N (Q28-V122), FBLN4-M (D123-R314),
FBLN4-C (C315-F443), Lox-WT, Lox-K314A, Lox-Y349A, LoxH283A, Lox-H286A, Lox-H288A, Lox-H290A, Lox-H297A, Fbln4-FL,
Fbln4-N (Q47-V141), Fbln4-M (D142-R333), Fbln4-C (C334-F462),
and ATP7A cDNA were amplified by polymerase chain reaction
(PCR) and subcloned into pENTR/ssHA, pENTR/ssbFLAG, pENTR/
cFLAG, pEF6/ssFLAG, pEF6/ssFLAG-hIgG, pENTR/atgFLAG, and
pENTR/atgMyc. Atp7a cDNA was synthesized (Thermo Fisher Scientific) to generate silent mutations to stabilize this gene in high-copy
plasmid during replication in Escherichia coli (38) and subcloned
into pENTR/atgFLAG. Atp7a-TM1–4 (K794-L1397) and Atp7a-
TM5–8 (F646-D927) cDNA were amplified by PCR and subcloned
into pENTR/atgFLAG. YF mutant Lox cDNA, in which all potentially sulfated tyrosine residues (Y177, Y178, Y180, Y181, and Y184)
of mouse LOX were substituted by phenylalanine residues (25), was
generated by PCR-based mutagenesis using pENTR-Lox-cFLAG as
a template. The entry clones were recombined with pLenti6.3 destination vectors using Gateway Technology (Invitrogen). Lentiviral
particles were produced via cotransfection of 293T cells with the
packaging plasmids using PEI MAX (Polysciences). Supernatants
were collected starting from 40 hours after transfection for 24 to
48 hours and concentrated using Lenti-X Concentrator (Clontech)
according to the manufacturer’s instructions. The resulting viral
pellet was resuspended in culture medium at ~1/10 of the original
volume, and the viral aliquot was stored frozen. Using Ni-NTA affinity resin (Qiagen), recombinant fibulin-4 or fibulin-5 was purified from serum-free conditioned medium of 293T cells stably
expressing fibulin-4 or fibulin-5 with N-terminal His-tags (21, 34).
In vitro binding assay
293T cells were transfected with the plasmids using PEI MAX (Polysciences). The transfected cells were cultured in serum-free DMEM/
F12 (Thermo Fisher Scientific). The conditioned medium (proLOX)
or the cell lysates (ATP7A) and fibulin-4 and its mutants (recombinant
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monooxygenase, enzymes necessary for melanin production or prohormone maturation, respectively (27). How fibulin-4 affects copper transfer is not yet known. We cannot exclude the possibility that
binding with fibulin-4 alters the conformation of proLOX so that it
can incorporate copper ion, which does not necessarily contradict
with the bridging model shown in Fig. 6I. Further study is needed to
examine this possibility.
The finding that the addition of recombinant fibulin-4 to cell
culture medium could promote the formation of LTQ in LOX was
unexpected, because copper transfer to proLOX and subsequent
LTQ formation occurs in the TGN (27). Very low concentrations (1
to 2 nM) of fibulin-4 in the medium were sufficient to induce LTQ
formation in LOX, suggesting that fibulin-4 may work as a circulating factor for LOX activation. There is a report showing that high
serum levels of fibulin-4 are associated with ovarian cancer (normal
~30 ng/ml versus cancer ~300 ng/ml) (36). This reported normal
level of fibulin-4 (~30 ng/ml = ~0.6 nM) corresponds to a concentration that can partially (~50%) induce LTQ formation in LOX
(Fig. 6A). Identification of the receptor for fibulin-4 for endocytosis
and measuring the concentrations of fibulin-4 in circulating blood
in various ages and in developmental stages require further investigation. It would also be interesting to see whether ectopic expression of fibulin-4 could rescue the phenotypes of Fbln4−/− mice to
understand the role for circulating fibulin-4 in vivo.
Together, our results show that fibulin-4 is essential for the formation of enzymatically active LOX and, hence, for elastic fiber formation and collagen fibrillogenesis. Endogenously expressed fibulin-4
or endocytosed fibulin-4 that is transported to the TGN promotes
copper ion transfer from ATP7A to proLOX, which is necessary for
the formation of LTQ, an intramolecular cross-link that works as a
cofactor for the oxidase activity of LOX (Fig. 6I). Our findings provide insights into the mechanism of ECM maturation and diseases
that involve fibrosis or insufficient elastogenesis.
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protein or conditioned medium) were mixed and subjected to immunoprecipitation with anti-FLAG M2 affinity gel (Sigma-Aldrich)
followed by SDS-PAGE with NuPAGE Bis-Tris acrylamide gel (4 to
12%) and MOPS or MES buffer (Thermo Fisher Scientific) and Western
blotting as described previously (39). N-terminal FLAG-tagged
bacterial alkaline phosphatase (FLAG-BAP) fusion protein was purchased from Sigma-Aldrich.

Purification of endogenous LOX and N-terminal amino
acid sequence
For the purification of endogenous mature LOX from the culture
medium, DEAE Sepharose Fast Flow was added to the medium. After
several hours of incubation followed by washing, the DEAE-bound
LOX was eluted by 1 M NaCl and 6 M urea in 10 mM phosphate
buffer (PB). The eluates were dialyzed with PB, followed by separation using Sephacryl S-200 HR (GE Healthcare) that works as an
affinity column for LOX (40). After washing, LOX was eluted with
6 M urea in PB. The eluates were concentrated by ultrafiltration. The
concentration of purified LOX was quantified as described previously (39).
Purified LOX protein was electrophoresed on a 4 to 12% SDS–
polyacrylamide gel and then transferred onto a polyvinylidene difluoride (PVDF) membrane operated at 30 V for 1 hour. After the
membrane was stained with SimplyBlue SafeStain (Thermo Fisher
Scientific), the purified LOX band was excised and analyzed using a
PPSQ-33A amino acid sequencer system (Shimadzu).
Enzymatic activity measurement of LOX
Rates of oxidation of peptidyl lysine were assessed using the tritiated
recombinant human tropoelastin as substrates, as described previously (41) with some modifications. Plasmids encoding human tropo
elastin cDNA (pTrc His3-hELN) were transformed into One Shot
Stbl3 Chemically Competent E. coli (Thermo Fisher Scientific). A
10-ml aliquot of an overnight culture of bacteria was diluted in 90 ml
of LB medium containing ampicillin (50 g ml−1), and the freshly
inoculated culture was incubated with shaking at 37°C overnight.
The cells were collected and washed twice with phosphate-buffered
saline (PBS) by centrifugation; the cell pellet was suspended in 160 ml
of lysine-free RPMI 1640 medium (Sigma-Aldrich) with 1.15 mM
arginine, 0.38 mM leucine, [L-4,5-3H]lysine (1.6 mCi/liter; 80 to 110 Ci
mmol−1), and 2 mM isopropyl--d(−)-thiogalactopyranoside (Wako
Noda et al., Sci. Adv. 2020; 6 : eabc1404
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Collagen and elastin cross-link analysis
The dissected aortae (n = 5 per genotype; four samples were pooled
for a single analysis) were subjected to amino acid analysis and elastin and collagen cross-link analyses as described (42). Briefly, the
samples were pulverized in liquid nitrogen, washed with cold PBS
and cold distilled water by repeated centrifugation at 4000g for 30 min,
and lyophilized. An aliquot of each (∼2 mg) was hydrolyzed with
6 N HCl and subjected to amino acid analysis. Desmosine and isodesmosine were quantified as residues per 1000 amino acids based on
the commercially available standards. Aliquots of the hydrolysates
with known amounts of hydroxyproline were also subjected to collagen cross-link analysis. The major nonreducible cross-link pyridinoline was quantified as moles/mole of collagen.
NBT and amido black staining of the membrane
For NBT staining, the PVDF membrane with transferred protein
was immersed in 0.24 mM NBT (Wako Pure Chemical) in 2 M potassium glycinate solution (pH 10.0) for 45 min in the dark. For
amido black staining, the membrane was stained with 0.1% amido
black (Wako Pure Chemical) in 45% methanol/10% acetic acid for
1 min, followed by destaining with 90% methanol/2% acetic acid
three times for 1 min each. The intensity of stained bands was quantified using ImageJ software [National Institutes of Health (NIH),
Bethesda, MD].
Detection and quantification of cross-linked and
non–cross-linked fragment of LOX
Purified LOX was incubated with 1 mM phenylhydrazine at 25°C
for 1 hour and 37°C for 30 min, followed by dialysis with 2 M urea
in PB. After adding ammonium bicarbonate to a concentration of
50 mM to 0.2 g of LOX solution, disulfide bonds were reduced by
adding dithiothreitol to a concentration of 50 mM and incubating
at 56°C for 1 hour. Subsequently, free sulfhydryl groups were alkylated by adding iodoacetamide to a concentration of 50 mM and
incubating at 25°C for 1 hour. After these modifications, protein
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Immunodetection of endogenous and FLAG-tagged LOX
Proteins were extracted from mouse neonatal aorta tissues with 8 M
urea solution, and supernatants were collected. Equal loadings of protein extracts were subjected to SDS-PAGE with NuPAGE Bis-Tris
acrylamide gel (4 to 12%) and MES buffer (Thermo Fisher Scientific),
followed by Western blotting. Cultured MEFs were infected by lentiviral particles with the volume adjusted individually to secrete equivalent amount of recombinant proteins. The supernatants of MEFs
were replaced by serum-free Advanced DMEM/F12 (Thermo Fisher
Scientific) on the next day of infection and harvested at 48 to 72 hours
after replacement. The endogenous and FLAG-tagged LOX in the
medium were concentrated using DEAE Sepharose Fast Flow (GE
Healthcare), followed by SDS-PAGE with NuPAGE Bis-Tris acrylamide gel (4 to 12%) and MES buffer (Thermo Fisher Scientific) and
Western blotting. For quantification, blots were scanned, and the
integral density of specific bands was measured using Image Gauge
Ver. 4.22.

Pure Chemical) and incubated in this medium with shaking at 37°C
for 8 hours. The labeled cells were isolated by centrifugation and
dissolved in 8 M urea/PBS (pH 7.4) with stirring overnight at 4°C.
The suspension was centrifuged (10,000g, 30 min, 4°C), and the super
natant was loaded onto a HisTrap FF (GE Healthcare Life Sciences)
equilibrated with binding buffer [8 M urea/PBS (pH 7.4)] at 5.0 ml/min.
The bound protein was eluted with elution buffer (binding buffer
containing 200 mM imidazole). The eluate was dialyzed overnight
against PBS with Slide-A-Lyzer Dialysis Cassette 10K MWCO (Thermo
Fisher Scientific), concentrated to 20,000 cpm/l using Amicon Ultra
30K centrifugal filter devices (Merck Millipore), and used for lysine
oxidation assay.
Assay mixtures included purified LOX protein and 200,000 cpm
of the elastin substrate suspended or dissolved in 0.1 M sodium borate and 0.15 M NaCl (pH 8.0) in a total volume of 0.8 ml and were
incubated for 2 hours at 37°C. Tritiated water formed during the
incubation was isolated from the elastin substrate by the trichloroacetic acid precipitation method, and radioactivity in 0.7-ml aliquot
of the supernatants was quantified by liquid scintillation spectrometry. The radioactivity was corrected for each enzyme-free control,
and all enzyme activities in the assay mixtures were ≥90% inhibited
by the inclusion of 50 M -aminopropionitrile, a specific inhibitor
of LOX.
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Determination of Cu concentration by ICP-MS
A 30-l aliquot of samples was wet-ashed with 50 l of nitric acid
(analytical grade, Wako Pure Chemical Industries) on a hot plate.
The samples were then diluted with 1% nitric acid to 300 l, followed by measurement using an inductively coupled plasma mass
spectrometer (ICP-MS; Agilent 8800, Agilent Technologies). The
signal intensities of Cu were monitored at m/z 65 with the integration time of 0.1 s, and the Cu concentration was calculated using a
standard calibration method.
Immunocytochemistry
Fbln4−/− MEFs were seeded on a glass-bottom dish. The next day,
the cells were incubated with culture medium containing recombinant FLAG-FBLN4 (40 nM) with or without endocytosis inhibitors
Dynasore (Santa Cruz Biotechnology) and Filipin (LKT Laboratories). The inhibitors were present in all steps except for the washing
buffer. After 3 hours of incubation, the cells were placed on ice and
washed with ice-cold PBS. After 5 min, the cell surface–bound FLAG-
FBLN4 was labeled by incubating the cells with ice-cold culture medium containing anti-FLAG antibody. After incubation for 30 min
on ice, the cells were washed twice with ice-cold PBS and then incubated with warm culture medium at 37°C to allow the internalization. The internalization was stopped by placing the cells on ice and
washing with ice-cold PBS. To remove uninternalized cell surface–
bound antibodies, the cells were washed with ice-cold acid wash
buffer containing 50 mM glycine and 150 mM NaCl (pH 2.0) for
1 min, followed by washing with PBS to neutralize the pH. The cells
were then fixed with 4% paraformaldehyde, washed with PBS, perNoda et al., Sci. Adv. 2020; 6 : eabc1404
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meabilized with 1% Triton X-100, and blocked with 5% bovine
serum albumin (BSA)/PBS for 1 hour. To visualize cell surface
and internalized anti-FLAG antibody bound to FLAG-FBLN4, a
fluorescence-conjugated secondary antibody was used. The cells
were observed using a BZ-9000 microscope (Keyence) and an LSM
700 microscope (Zeiss). Intensity of the signal was quantified using
ArrayScan VTI (Thermo Fisher Scientific).
Statistics
Comparisons were made using Student’s t test between two groups.
Analyses across multiple groups were made using a one-way analysis
of variance (ANOVA) with Dunnett’s multiple comparisons post
hoc test. P values less than 0.05 were considered to be significant.
SUPPLEMENTARY MATERIALS

Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/6/48/eabc1404/DC1
View/request a protocol for this paper from Bio-protocol.
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